Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings

Radiology

Volumn 206, Issue 3, 1998, Pages 755-760

  Abdel Nabi, Hani ^a   Doerr, Ralph J ^b   Lamonica, Dominick M ^a   Cronin, Valerie R ^a   Galantowicz, Paul J ^a   Carbone, Gregory M ^a   Spaulding, Monica B ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

Colon, neoplasms; Emission CT (ECT); Fluorine; Rectum, neoplasms

Indexed keywords

BARIUM SULFATE; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; IOHEXOL; IOPAMIDOL;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHOLE BODY TOMOGRAPHY;

EID: 0031882858     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.206.3.9494497     Document Type: Article

References (19)

1. Cancer facts and figures. Part 9. Atlanta, Georgia: American Cancer Society, 1995.
2. Steele GD. The National Cancer Database report on colorectal cancer. Cancer 1994; 74:1979-1989.
3. Ferrucci JT. Liver tumor imaging: current concepts. AJR 1990; 155:473-484.
4. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cook TG, McArdle CS. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 1995; 195:113-116.
5. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32:623-640.
6. 18F] fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994; 81:1666-1670.
7. Schiepers C, Pennincky F, DeVadder N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 1995; 21:517-522.
8. Rigo P, Paulus P, Kastchen BJ, et al. Oncology applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23:1641-1674.
9. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989; 170:329-332.
10. Ito K, Kato T, Tadokoro M, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 1992; 182:549-552.
11. Abdel-Nabi H, Lamonica D, Spaulding M, et al. Localization of occult/recurrent colorectal cancers with F-18 FDG whole body PET: comparison with conventional diagnostic modalities (abstr). J Nucl Med 1995; 36(suppl):106P.
12. Gupta NC, Falk PM, Frank AL, Thorson AM, Frick MD, Bowman B. F-18 fluorodeoxyglucose (FDG) PET for preoperative staging of colorectal carcinoma (abstr). J Nucl Med 1992; 33:975.
13. Cronin V, Galantowicz P, Murphy B, et al. Optimal processing of metastatic tumors in patients (pts) undergoing positron emission tomography (PET) whole body imaging with F-18 FDG (abstr). J Nucl Med Tech 1995; 23:116-117.
14. Cronin V, Galantowicz P, Bednarczyk E, et al. Effect of positioning of region of interest (ROI) in patients undergoing positron emission tomography (PET) with F-18 FDG and its influence in varying standardized uptake values (SUV) (abstr). J Nucl Med Tech 1996; 24:169.
15. Falk PM, Gupta NC, Thorson AG, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994; 37:153-156.
16. Abdel-Nabi H, Schwartz AN, Higano CS, Wechter DG, Unger MW. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic antigen monoclonal antibody ZCE025. Radiology 1987; 164: 617-621.
17. Vitola JV, Delbeke D, Sandler MP, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996; 171:4-26.
18. Lamki LM. Positron emission tomography in oncology: general acceptance of its role is overdue. Cancer 1996; 78: 2039-2042.
19. Barrington SF, Maisey MN. Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 1996; 37:1127-1129.